January 10, 2018 / 7:03 AM / a month ago

BRIEF-Shanghai Pharmaceuticals Holding units receive GMP certificate

Jan 10 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd

* Says Changzhou-based pharmaceuticals unit received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration, for its products including acyclovir, ganciclovir and production line

* Says the valid period is until Dec. 25, 2022

* Says Shanghai-based pharmaceuticals unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration, for its products including flurbiprofen axetil

* Says the valid period is until Dec. 26, 2022

Source text in Chinese:goo.gl/15PQTv

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below